Cyclerion Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- 1
- Market Cap
- $6.9M
- Website
- http://www.cyclerion.com
- Introduction
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers
- First Posted Date
- 2015-10-08
- Last Posted Date
- 2019-04-03
- Lead Sponsor
- Cyclerion Therapeutics
- Target Recruit Count
- 24
- Registration Number
- NCT02572349
- Locations
- 🇺🇸
Ironwood Investigational Site, San Antonio, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath